Copyright © 1993 by the European Society of Cardiology.
© 1993 The European Society of Cardiology
Vasodilator reserve in collateral-dependent myocardium as measured by positron emission tomography







*Department of Cardiology, VA Hospital, University of Minnesota Minneapolis MN, U.S.A.
Department of Nuclear Medicine, University of Pennsylvania Philadelphia PA, U.S.A.
MRC Cyclotron Unit, Hammersmith Hospital London U.K.
Received 21 September 1992; .
Correspondence: Edward McFalls, MD, PhD, Division of Cardiology, VA Medical Center, University of Minnesota, 1 veterans Drive, Minneapolis MN 55417, U.S.A.
Abstract
Myocardial blood flow can be accurately quantitated in patients using positron emission tomography and oxygen-15 labelled water. The purpose of this study was to determine the vasodilator reserve in myocardium completely perfused by intramyocardial collateral blood flow. We hypothesized that altered relative flow reserve in such regions would correlate with the degree of ischaemia observed in these patients during exercise.
The technique involves the inhalation of the positron emitting tracer C15O2 which is converted to freely diffusible H215O by the lung. With rapid dynamic scanning, arterial and regional myocardial tissue concentrations can be obtained and time activity curves generated. With a two-compartment kinetic model, myocardial blood flow can be accurately quantitated over a wide range of blood flows. Five patients with stable exertional angina and normal ventricular function studies and who had an occluded major epicardial artery which completely opacified via intramyocardial collateral blood flow were studied. Myocardial blood flow (MBF) was measured both at rest and following an infusion of intravenous dipyridamole (0.56 mg. kg1) and the results were compared with measurements obtained from a group of eight normal volunteers. During resting conditions, MBF in the control group was 0.86±0.10ml. g1. min1 and in the patient group was 0.99±0.10 ml. g1. min1 in normally perfused myocardium (ns) and 0.86±0.14 ml. g1. min1 in collateral-dependent myocardium (ns). Following dipyridamole, MBF increased to 3.58±0.89 ml. g1. min1 in the control group and to 2.97±0.94 ml. g1. min1 in the normal regions of the patients (ns). In the collateralized regions of the patients, the increase was less than that observed in the control group (1.66±1.02, P <0.005). Absolute coronary flow reserve (ACFR) (dipyridamole MBF/resting MBF) in the control group was 4.1±0.8 and in the patient group was 3.1±1.1 (ns) in normal regions and 1.9± 1.0 (P <0.001) in collateralized regions. Relative coronary flow reserve, the ratio of ACFR in collateralized vs that of normally perfused myocardium was determined in each patient and correlated well with total exercise time (r = 0.98; P <0.01) and peak double product (r = 0.85; P = 0.06) observed during a symptom-limited modified Bruce treadmill test.
These studies support the hypothesis that vasodilator reserve in the distribution of non-infarcted collateral-dependent myocardium is abnormal compared with normally perfused myocardium. The degree of altered flow reserve correlates well with the degree of ischaemia during symptom-limited exercise, and may explain why these patients experience angina at high work loads.
Key Words: Positron emission tomography collateral blood flow flow reserve
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
E. Chammas, A. Hussein, G. Ballane, A. Helou, A. Yatim, W. Tarcha, and G. Ghanem Myocardial Perfusion in Patients With a Totally Occluded Left Anterior Descending Coronary Artery Reinjected by a Normal Right Coronary Artery: The Role of Collateral Circulation Angiology, August 1, 2008; 59(4): 464 - 468. [Abstract] [PDF] |
||||
![]() |
R. Topsakal, N. K. Eryol, A. Abaci, S. Oymak, I. Ozdogru, Y. Yilmaz, E. Seyfeli, A. Oguzhan, and A. Ergin The Relation Between Chronic Obstructive Pulmonary Disease and Coronary Collateral Vessels Angiology, November 1, 2005; 56(6): 651 - 656. [Abstract] [PDF] |
||||
![]() |
G. S. Werner and H. R. Figulla Direct Assessment of Coronary Steal and Associated Changes of Collateral Hemodynamics in Chronic Total Coronary Occlusions Circulation, July 23, 2002; 106(4): 435 - 440. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Billinger, M. Fleisch, F. R. Eberli, B. Meier, and C. Seiler Collateral and collateral-adjacent hyperemic vascular resistance changes and the ipsilateral coronary flow reserve: Documentation of a mechanism causing coronary steal in patients with coronary artery disease Cardiovasc Res, February 16, 2001; 49(3): 600 - 608. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. O. Akinboboye, O. Idris, R.-L. Chou, R. R. Sciacca, P. J. Cannon, and S. R. Bergmann Absolute quantitation of coronary steal induced by intravenous dipyridamole J. Am. Coll. Cardiol., January 1, 2001; 37(1): 109 - 116. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Seiler, M. Fleisch, M. Billinger, and B. Meier Simultaneous intracoronary velocity- and pressure-derived assessment of adenosine-induced collateral hemodynamics in patients with one- to two-vessel coronary artery disease J. Am. Coll. Cardiol., December 1, 1999; 34(7): 1985 - 1994. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. M. van Liebergen, J. J. Piek, K. T. Koch, R. J. de Winter, C. E. Schotborgh, and K. I. Lie Quantification of collateral flow in humans: a comparison of angiographic, electrocardiographic and hemodynamic variables J. Am. Coll. Cardiol., March 1, 1999; 33(3): 670 - 677. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Schulz, H. Post, A. Jalowy, U. Backenkohler, H. Dorge, C. Vahlhaus, and G. Heusch Unique Cardioprotective Action of the New Calcium Antagonist Mibefradil Circulation, January 19, 1999; 99(2): 305 - 311. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Piek, R. A. M. van Liebergen, K. T. Koch, R. J. de Winter, R. J. G. Peters, and G. K. David Pharmacological Modulation of the Human Collateral Vascular Resistance in Acute and Chronic Coronary Occlusion Assessed by Intracoronary Blood Flow Velocity Analysis in an Angioplasty Model Circulation, July 1, 1997; 96(1): 106 - 115. [Abstract] [Full Text] |
||||
![]() |
F. S. Villanueva, J. A. Abraham, G. F. Schreiner, M. Csikari, D. Fischer, J. D. Mills, U. Schellenberger, B. J. Koci, and J. S. Lee Myocardial Contrast Echocardiography Can Be Used to Assess the Microvascular Response to Vascular Endothelial Growth Factor-121 Circulation, February 12, 2002; 105(6): 759 - 765. [Abstract] [Full Text] [PDF] |
||||



